Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
BMC Cardiovasc Disord ; 23(1): 225, 2023 05 01.
Artigo em Inglês | MEDLINE | ID: mdl-37127559

RESUMO

BACKGROUND: Cardiac sarcoidosis is found to occur in approximately 5% of patients with sarcoidosis. Its presentation can typically range from complete heart block to ventricular arrhythmias. This condition can rarely present with severe heart failure and cardiogenic shock requiring aggressive and timely management strategies. Advanced imaging techniques are usually required to assist with its diagnosis. CASE PRESENTATION: A 70-year-old woman with a history of pulmonary sarcoidosis presented with non-ST elevation myocardial infarction, congestive hepatopathy, and acute renal failure. Left heart catheterization showed evidence of non-obstructive coronary artery disease, and right heart catheterization revealed severely elevated filling pressures and depressed cardiac index. She underwent aggressive diuresis and placement of an intra-aortic balloon pump in addition to initiation of inotropic and vasopressor support. While in the cardiac intensive care unit, she experienced frequent episodes of ventricular tachycardia and went into cardiac arrest requiring cardiopulmonary resuscitation. High clinical suspicion for cardiac sarcoidosis was confirmed by cardiac magnetic resonance imaging findings. After starting immunosuppressive therapy for cardiac sarcoidosis, she demonstrated clinical improvement. CONCLUSION: Patients with cardiac sarcoidosis may remain asymptomatic or present with conduction abnormalities and arrhythmias. They rarely present with severe biventricular heart failure and cardiogenic shock, and in such cases, they require timely initiation of pharmacologic and device therapies, along with implementation of mechanical circulatory support.


Assuntos
Parada Cardíaca , Insuficiência Cardíaca , Coração Auxiliar , Miocardite , Sarcoidose , Feminino , Humanos , Idoso , Choque Cardiogênico/etiologia , Insuficiência Cardíaca/complicações , Coração Auxiliar/efeitos adversos , Parada Cardíaca/complicações , Arritmias Cardíacas/complicações , Miocardite/complicações , Resultado do Tratamento
2.
Med Princ Pract ; 31(4): 342-351, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35584616

RESUMO

The UK government had intended to introduce a comprehensive Electronic Health Record (EHR) system in England by 2020. These EHRs would run across primary, secondary, and social care, linking data in a single digital platform. The objectives of this systematic review were to identify studies that compare EHR in terms of direct comparison between systems and to evaluate them using System and Software Quality Requirements and Evaluation (SQuaRE) ISO/IEC 25010. A systematic review was performed by searching Embase and Ovid MEDLINE databases between 1974 and April 2021. All original studies that appraised EHR systems and their providers were included. The main outcome measures were EHR system comparison and the eight characteristics of SQuaRE: functional suitability, performance efficiency, compatibility, usability, reliability, security, maintainability, and portability. A total of 724 studies were identified using the search criteria. After a review of titles and abstracts, this was filtered down to 40 studies as per the exclusion and inclusion criteria set out in our study. Seven studies compared more than one EHR. The following number of studies looked at the various aspects of the SQuaRE, respectively - 19 studies: functional suitability, performance efficiency: 18 studies, compatibility: 12 studies, usability: 25 studies, reliability: 6 studies, security: 2 studies, maintainability: 16 studies, portability: 13 studies. Epic was the most studied EHR system and one of the most implemented systems in the US market and one of the top ten in the UK. It is difficult to assess which is the most advantageous EHR system when they are assessed by SQuaRE's 8 characteristics for software evaluation.


Assuntos
Registros Eletrônicos de Saúde , Software , Humanos , Reprodutibilidade dos Testes
3.
Vet Med Sci ; 7(6): 2362-2373, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34472216

RESUMO

BACKGROUND: Sexual differentiation can occur after exposure to aromatase into the left gonad at 6.5 days of incubation. Aromatase inhibitors work by inhibiting the action of the aromatase, which converts androgens into estrogens by a process called aromatization. OBJECTIVES: The aim of this study was to investigate the effect of in ovo exposure to the aromatase inhibitor from tomato and garlic extract on sexual differentiation and embryonic development in chicken embryos. METHODS: Three hundred eggs divided into five groups: Control 1 (CO; no injection); control 2 distilled water, DW; 0.1 ml/egg); garlic extract (GAR; 0.1 mg/egg); tomato extract (TOM; 0.1 mg/egg); and garlic and tomato extract mixed (ATM, 0.1 ml/egg). The solution was prepared and injected into the albumin from the thin end of the eggs on day five by using a 1 ml syringe with a 23-gauge needle. The embryonic test (embryo/egg weight) conducted at 7, 14 and 17 days of incubation. After hatching, feather sexing conducted to determine the initial male. Chicks sex was later confirmed on day 42 by an optical microscope lens. RESULTS: The results revealed that there was a significant increase (p < 0.01) in embryonic growth traits in all experimental treatments as compared to control treatments. There was a significant increase (p < 0.01) in the percentage of hatchability for all experimental treatments compared to control treatments and a significant increase (p < 0.01) in chick quality including one-day-old chick length and body weight. All experimental treatments showed a significant increase (p < 0.01) in the male-to-female ratio compared to control treatments. CONCLUSIONS: The effect of in ovo exposure to aromatase inhibitors stimulated female-to-male sex reversal and improved embryonic development.


Assuntos
Galinhas , Diferenciação Sexual , Animais , Inibidores da Aromatase/farmacologia , Embrião de Galinha , Desenvolvimento Embrionário , Plumas , Feminino , Masculino
4.
Int J Environ Res Public Health ; 3(4): 360-8, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17159279

RESUMO

In big cities, the cost of treating wastewater is increasing with more stringent environmental requirements. Ionizing radiation technology for treating municipal wastewater may be an alternative to reduce treatment costs. In this paper, laboratory tests were carried out using different doses of radiation to treat wastewater samples collected from the AL-Rustamia wastewater treatment plant in Baghdad city. According to the results, irradiation by gamma radiation with a dose ranging from 100 to 500 krad was efficient in reducing some of the physical contaminants. The organic contaminants were degraded and reduced to about 12% of their original concentrations. Generally, irradiation technology could effectively modify the characteristics of the wastewater to such levels that are compatible with Iraqi disposal standards. The results of the study also showed that, an experimental pilot plant study is required to optimize the cost of wastewater treatment through the use of this technology.


Assuntos
Cidades , Poluentes da Água/efeitos da radiação , Purificação da Água/métodos , Abastecimento de Água , Condutividade Elétrica , Gorduras/efeitos da radiação , Testes de Dureza , Modelos Biológicos , Nefelometria e Turbidimetria , Óleos/efeitos da radiação , Oxigênio/química , Oxigênio/efeitos da radiação , Radiação Ionizante , Purificação da Água/instrumentação , Abastecimento de Água/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA